The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

Abstract Background Clinical management decisions on prostate cancer (PCa) are often based on a determination of risk. 68Ga-prostate-specific membrane antigen (PSMA)-11-positron emission tomography (PET)/computer tomography (CT) is an attractive modality to assess biochemical recurrence of PCa, dete...

Full description

Bibliographic Details
Main Authors: Jun-jie Hong, Bo-le Liu, Zhi-qiang Wang, Kun Tang, Xiao-wei Ji, Wei-wei Yin, Jie Lin, Xiang-wu Zheng
Format: Article
Language:English
Published: SpringerOpen 2020-11-01
Series:EJNMMI Research
Subjects:
18F-PSMA-1007
Prostate cancer
High risk
Online Access:http://link.springer.com/article/10.1186/s13550-020-00730-1

Internet

http://link.springer.com/article/10.1186/s13550-020-00730-1

Similar Items